A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study. - Burton ER; Brady M; Homesley HD; Rose PG; Nakamura T; Kesterson JP; Rotmensch J; Tate Thigpen J; Van Le L (Gynecologic oncology, 2016)